ATE12698T1 - Verfahren zur bestimmung von hepatitis-b-kernantik¯rpern in biologischen fluessigkeiten. - Google Patents

Verfahren zur bestimmung von hepatitis-b-kernantik¯rpern in biologischen fluessigkeiten.

Info

Publication number
ATE12698T1
ATE12698T1 AT79401025T AT79401025T ATE12698T1 AT E12698 T1 ATE12698 T1 AT E12698T1 AT 79401025 T AT79401025 T AT 79401025T AT 79401025 T AT79401025 T AT 79401025T AT E12698 T1 ATE12698 T1 AT E12698T1
Authority
AT
Austria
Prior art keywords
hepatitis
determination
procedure
biological fluids
sub
Prior art date
Application number
AT79401025T
Other languages
English (en)
Inventor
William J Miller
William J Mcaleer
Lynn T Callahan
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE12698T1 publication Critical patent/ATE12698T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B
    • G01N33/5762—Hepatitis B core antigen
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/964—Chemistry: molecular biology and microbiology including enzyme-ligand conjugate production, e.g. reducing rate of nonproductive linkage

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AT79401025T 1978-12-18 1979-12-17 Verfahren zur bestimmung von hepatitis-b-kernantik¯rpern in biologischen fluessigkeiten. ATE12698T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/970,721 US4241175A (en) 1978-12-18 1978-12-18 Assay for hepatitis B core antibody
EP79401025A EP0012699B1 (de) 1978-12-18 1979-12-17 Verfahren zur Bestimmung von Hepatitis-B-Kern-Antikörpern in biologischen Flüssigkeiten

Publications (1)

Publication Number Publication Date
ATE12698T1 true ATE12698T1 (de) 1985-04-15

Family

ID=25517396

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79401025T ATE12698T1 (de) 1978-12-18 1979-12-17 Verfahren zur bestimmung von hepatitis-b-kernantik¯rpern in biologischen fluessigkeiten.

Country Status (8)

Country Link
US (1) US4241175A (de)
EP (1) EP0012699B1 (de)
JP (1) JPS5587049A (de)
AT (1) ATE12698T1 (de)
CA (1) CA1137411A (de)
DE (1) DE2967431D1 (de)
DK (1) DK536279A (de)
IE (1) IE49628B1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK171727B1 (da) * 1978-12-22 1997-04-14 Biogen Inc Rekombinante hepatitis B virus DNA-molekyler, værtsorganismer transformeret hermed, HBV-antigenspecifikke polypeptider, DNA-sekvenser kodende for HBV-antigenspecifikke polypeptider, metoder til påvisning af hepatitis B virus-antistoffer, metoder til fremstilling af nævnte DNA-molekyler, fremgangsmåder til fremstilling af nævnte polypeptider og midler til påvisning af HBV-infektion
US6297355B1 (en) 1978-12-22 2001-10-02 Biogen, Inc. Polypeptides displaying HBV antigenicity or hbv antigen specificity
US4495295A (en) * 1979-05-21 1985-01-22 New York Blood Center, Inc. Immunoassays using support-containing separate antigens and antibodies derived from an immune complex
US4617260A (en) * 1981-02-27 1986-10-14 Merck & Co., Inc. RIA assay for HBcAg
WO1982003462A1 (en) * 1981-03-27 1982-10-14 Ltd Biospecia Immunological analysis and a biochemical agent therefore
US4562159A (en) * 1981-03-31 1985-12-31 Albert Einstein College Of Medicine, A Division Of Yeshiva Univ. Diagnostic test for hepatitis B virus
DE3273658D1 (en) * 1981-11-19 1986-11-13 New York Blood Center Inc Diagnostic reagent and use thereof
DE3327642A1 (de) * 1983-07-30 1985-02-14 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur bestimmung eines partners einer immunreaktion sowie reagens zur durchfuehrung dieses verfahrens
DE3477610D1 (en) * 1983-09-14 1989-05-11 Akzo Nv Method for the immunochemical determination of hepatitis b core antigens
GB8500918D0 (en) * 1985-01-15 1985-02-20 Cancer Res Inst Viral isolates
US4818688A (en) * 1986-11-21 1989-04-04 E. I. Du Pont De Nemours And Company Assays for antibody to hepatitis B core antigen
DE68907996T2 (de) * 1988-05-11 1994-01-05 Abbott Lab Verfahren zur Erhöhung der Spezifizität in kompetitiven Immuntests.
MY104234A (en) * 1988-11-17 1994-02-28 Becton Dickinson Co Immunoassay on a preblocked solid surface
WO1995016040A2 (en) * 1993-12-10 1995-06-15 The Canadian Red Cross Society Immunofluorescence assay for the detection of antibodies using recombinant antigens in insoluble form

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL125235C (de) * 1965-04-15
US3654090A (en) * 1968-09-24 1972-04-04 Organon Method for the determination of antigens and antibodies
US4148869A (en) * 1975-03-06 1979-04-10 Baxter Travenol Laboratories, Inc. Immunological reagent and method of using same
US3995019A (en) * 1975-03-04 1976-11-30 Baxter Travenol Laboratories, Inc. Diagnostic reagent system
SE7610683L (sv) * 1975-09-29 1977-06-10 Cordis Corp Metod for bestemning av nervaron av ett antigen associerat med hepatit
US4157280A (en) * 1975-09-29 1979-06-05 Cordis Corporation Test set for detecting the presence of antigens associated with hepatitis
US4100267A (en) * 1975-10-01 1978-07-11 Ortho Diagnostics Inc. Method of detecting hepatitis B core antigen and antibody
CA1100037A (en) * 1977-03-11 1981-04-28 Chung-Mei Ling Hb.sub.c ag coated on solid phase
US4102996A (en) * 1977-04-20 1978-07-25 Merck & Co., Inc. Method of preparing hepatitis B core antigen

Also Published As

Publication number Publication date
DK536279A (da) 1980-06-19
US4241175A (en) 1980-12-23
JPS5587049A (en) 1980-07-01
EP0012699B1 (de) 1985-04-10
CA1137411A (en) 1982-12-14
DE2967431D1 (en) 1985-05-15
EP0012699A1 (de) 1980-06-25
IE792430L (en) 1980-06-18
IE49628B1 (en) 1985-11-13

Similar Documents

Publication Publication Date Title
IE792430L (en) Detecting hepatitis b core antibody
DK0649535T3 (da) Fremgangsmåde til at forbedre målepræcisionen i optisk biosensor assays med detektering af rumligt dæmpede bølger
ATE21173T1 (de) Methode zur fluoreszenz-spektroskopischen bestimmung von biologisch aktiven substanzen.
ATE47231T1 (de) Verfahren zur bestimmung eines partners einer immunreaktion sowie reagens zur durchfuehrung dieses verfahrens.
ATE161041T1 (de) Verfahren zur hcv-züchtung in zell-linien aus b- oder t-lymphozyten
IE780716L (en) Hepatitis b core antigens.
DE3779704D1 (de) Verfahren und testkit zur bestimmung freier wirkstoffe in biologischen fluessigkeiten.
DE3486350D1 (de) VERFAHREN ZUR ISOLIERUNG EINES PROTEINS AUS EINER DIESES PROTEIN ENTHALTENDEN MISCHUNG UNTER VERWENDUNG EINES KONFORMATIONSSPEZIFISCHEN ANTIKöRPERS.
ES2099746T3 (es) Metodo de deteccion y/o dosificacion de hormonas.
LU81222A1 (fr) Reactif et methode de detection de l'hepatite b
DE69230917D1 (de) Verfahren zur detektion von hepatitis c
DE3853465D1 (de) Testträger zur Analyse einer Probenflüssigkeit und Verfahren zu seiner Herstellung.
DE68900106D1 (de) Verfahren zur bestimmung der freien ligandenfraktion einer biologischen fluessigkeit.
SE8004542L (sv) Diagnostiskt test
ATE67315T1 (de) Verfahren zur durchfuehrung von immunfluoreszenztesten.
WO1993025662A3 (en) Replication of hepatitis c virus genome and identification of virus having high infectivity
SE7907118L (sv) Bestemning av human beta?712-mikroglobulin
EP0286264A3 (de) Test zum Nachweis von Hepatitisantigenen und Aidsantikörpern
FI861205A0 (fi) Foerfarande foer koncentration och detektering av biomolekyler och celler och medel foer detta.
ATE2048T1 (de) Isolierung von hepatitis be-antigen.
ATE77487T1 (de) Immunologisches bestimmungsverfahren zur bestimmung von hapteneigenschaften aufweisenden freien substanzen.
FR2383446A1 (fr) Reactifs et procedes pour la mise en evidence de l'anticorps antinoyaux de dane
ATE42002T1 (de) Verfahren zur immunochemischen bestimmung von hepatitis-b-core-antigenen.
ATE107031T1 (de) Verfahren zur bestimmung eines liganden.
ATE14161T1 (de) Verfahren zur bestimmung von immunkomplexen.